Concepedia

Evert-Jan Breman

EB

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2024

Affiliations

FF Pharma (Netherlands)(Current)

Evert-Jan Breman is an author at FF Pharma (Netherlands) specializing in dose escalation therapy, tolerogenic dendritic cells, and immunotherapy.

Publications per year

2024–2024

1

Publications

1

Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis

Arie Jan Stoppelenburg, Gerty Schreibelt, Bouke Koeneman et al. · BMJ Open · 2024 · 10 citations · Full text

, , +17

1–1 of 1